Sephience Powder
Product Images NDC 60468-007

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sephience (NDC 60468-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allphamed Pharbil Arzneimittel Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box (Box)

This product is an oral powder containing 1,000 mg per packet of Sephience (sepiapterin). The directions for use recommend taking it with food. Each packet is a unit dose. The manufacturer of this product is PTC Therapeutics, Inc.*

FDA Label Image

Inner Label0 (Inner Label0)

This text appears to contain information about a medication named "Sephience" in oral powder form, with each packet containing 1,000 mg. The product is associated with a specific NDC number (52856-301-01) and comes in unit-dose packets meant to be taken with food. The packaging includes usage directions and guidelines for administration. The medication is manufactured for PTC Therapeutics, Inc. with details on lot and expiration dates provided on the packaging.*

FDA Label Image

Inner Label2 (Inner Label2)

This is a description of a medication called Sephience, which is an oral powder containing sepiapterin. Each packet contains 250 mg of the powder and should be taken with food. The medication is manufactured for PTC Therapeutics, Inc. The National Drug Code (NDC) for this medication is 52856-201-01. The packet is a unit-dose packet with instructions enclosed for administration.*

FDA Label Image

Outer Label0 (Outer Label0)

This is a document providing information regarding a pharmaceutical product called Sephience, which is an oral powder containing 1,000 mg per packet of sepiapterin. The directions specify to take it with food, and there are 30 unit-dose packets in each box. The product does not contain preservatives, and any unused portion should be discarded. The recommended dosage and storage instructions are provided. The text also includes details about PTC Therapeutics, the manufacturer of Sephience.*

FDA Label Image

Outer Label2 (Outer Label2)

This is a description of a medication called Sephience, which is in the form of an oral powder. Each packet contains 250 mg of the medication. The directions advise taking it with food. It is recommended to store Sephience between 20°C to 25°C (68°F to 77°F). This medication is manufactured for PTC Therapeutics, Inc., located in Warren, NJ, USA. The packaging contains 30 unit-dose packets. Additionally, it is mentioned that Sephience contains no preservatives and any unused portion should be discarded. For more information about dosage, one should refer to the Prescribing Information enclosed.*

FDA Label Image

Chemical Structure (Sephience 01)

FDA Label Image

Figure 1 (Sephience 02)

This text provides information on Mean Blood Phe levels (in μmol/L) at different time points in a study involving a placebo-controlled trial. The data shows the levels at baseline, week 12, week 34, and week 56 for both the placebo and the "Sephience" treatment.*

FDA Label Image

250mg Dose Packet (Sephience 03)

This description is for a product called Sephience, an oral powder form of sepiapterin, with 250 mg per packet. Each box contains 30 individual packets of this product.*

FDA Label Image

1000mg Dose Packet (Sephience 04)

This is information about Sephience oral powder containing 1,000 mg per packet (sepiapterin). It comes in a box of 30 packets, each of which is 1,000 mg. Sephience may be used for various purposes, but detailed usage instructions are not provided in the text.*

FDA Label Image

Figure A (Sephience 05)

This is a list of items included and not included in a product package. The package includes SEPHIENCE oral powder packets, but does not include an oral dosing syringe or scissors. It also mentions a container for mixing water or apple juice.*

FDA Label Image

Figure B (Sephience 06)

This text mentions a "Figure B" and a container used for mixing. It suggests that there may be an illustration or diagram showing a container designed for mixing substances or ingredients.*

FDA Label Image

Figure C (Sephience 07)

This text is a list of items including a barrel, plunger, oral dosing syringe, container for water or apple juice, and a mixing cup. These items appear to be related to a specific product or kit, possibly for medical or culinary purposes.*

FDA Label Image

Figure D (Sephience 08)

A container labeled "Figure D" is intended for mixing purposes, providing a convenient solution for blending different ingredients or substances together.*

FDA Label Image

Figure E (Sephience 09)

FDA Label Image

Figure F (Sephience 10)

FDA Label Image

Figure G (Sephience 11)

FDA Label Image

Figure A1 (Sephience 12)

This is a list mentioning items included and not included with Figure A, which seems to be related to SEPHIENCE oral powder packets. The items mentioned include containers, water, applesauce, apple juice, strawberry jam, and a tablespoon. The purpose of these items may be for mixing or rinsing when using the oral powder packets.*

FDA Label Image

250mg Foil (Sephience 13)

FDA Label Image

1000mg Foil (Sephience 14)

This is a description of a product called "Sephience" (sepipten) oral powder that contains 250mg per packet.*

FDA Label Image

Figure B1 (Sephience 15)

FDA Label Image

Figure C1 (Sephience 16)

This text provides instructions for making a fruit-based drink. It mentions using applesauce or strawberry jam in a cup, followed by adding a tablespoon of a liquid, likely water, and pouring apple juice into a container for mixing.*

FDA Label Image

Figure D1 (Sephience 17)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.